Sagent Pharmaceuticals, Inc. Reports Second Quarter 2013 Financial Results

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SCHAUMBURG, Ill., Aug. 6, 2013 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical products with an emphasis on the injectable market, today announced financial results for the quarter ended June 30, 2013.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC